Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sensus Healthcare (SRTS) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Sensus Healthcare (SRTS) over the last 10 years, with Q3 2025 value amounting to -$943000.0.

  • Sensus Healthcare's Net Income towards Common Stockholders fell 17761.32% to -$943000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year decrease of 13228.44%. This contributed to the annual value of $6.6 million for FY2024, which is 127051.55% up from last year.
  • Sensus Healthcare's Net Income towards Common Stockholders amounted to -$943000.0 in Q3 2025, which was down 17761.32% from -$1.0 million recorded in Q2 2025.
  • Sensus Healthcare's Net Income towards Common Stockholders' 5-year high stood at $5.3 million during Q4 2021, with a 5-year trough of -$631.3 million in Q1 2022.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was $195000.0 (2021), whereas its average is -$32.4 million.
  • As far as peak fluctuations go, Sensus Healthcare's Net Income towards Common Stockholders surged by 194520.37% in 2021, and later tumbled by 5651793.72% in 2022.
  • Sensus Healthcare's Net Income towards Common Stockholders (Quarter) stood at $5.3 million in 2021, then crashed by 46.8% to $2.8 million in 2022, then soared by 48.82% to $4.2 million in 2023, then tumbled by 63.28% to $1.5 million in 2024, then tumbled by 161.0% to -$943000.0 in 2025.
  • Its Net Income towards Common Stockholders was -$943000.0 in Q3 2025, compared to -$1.0 million in Q2 2025 and -$2.6 million in Q1 2025.